AAT-008

N/A

Report date: 2024/10/29 15:29:45
NME

Base Information

Drug NameAAT-008
Drug Alias NameAAT-008RQ-00000008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid EP4 receptor antagonists
TargetsProstanoid EP4 receptor
Therapy Area/IndicationsPainInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEUMainland China +[4] 
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesElanco Animal Health IncorporatedIkena Oncology IncArrys Therapeutics Inc +[6] 
Inactive CompaniesN/A
Active IndicationsPainInflammationNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A